Buy Raloxifene Hydrochloride (Raloxifene HCL) Powder

Buy Raloxifene Hydrochloride (Raloxifene HCL) Powder

Raloxifene Hydrochloride

Product Name:   Raloxifene Hydrochloride Powder

CAS #:   82640-04-8

Purity:   99%

Raloxifene Hydrochloride Price:   According to your needs

Raloxifene Hydrochloride Half Life:  27 hours

Raloxifene Hydrochloride Dosage:   60 mg orally per day

Raloxifene Hydrochloride Detection time:   Currently unknown

Raloxifene Hydrochloride Side Effect:   Coughing blood;headache or migraine headache;loss of or change in speech, coordination, or vision;pain or numbness in chest, arm, or leg shortness of breath

Raloxifene Hydrochloride Results:   For treatment or prevention of osteoporosis, advise patients to add supplemental calcium and/or vitamin D if daily intake is inadequate;When this drug is used to reduce the risk of invasive breast cancer, the optimum duration of treatment is not known.

Raloxifene Hydrochloride Specifications:


Appearance White &off-white powder Conform
Solubility Soluble in 10% sodium hydroxide solution. Slightly Soluble in methanol. Insoluble in water Conform
Identifications Infrared Absorption Conform
Chloride Conform
Tests Loss on drying ≤0.5% 0.4%
Residue on ignition ≤0.1% 0.06%
Heavy metals ≤10ppm Conform
RRelated substances Raloxifene Impurity1 ≤0.20 % 0.10%
Any unspecified individual impurity 2 ≤0.10% Max. 0.08%
Total impurities ≤0.50% 0.40%
Assay Raloxifene HCl ≥98.0% 99.0%

Raloxifene Hydrochloride Descriptions:

EVISTA (raloxifene hydrochloride) is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM) that belongs to the benzothiophene class of compounds.
The chemical designation is methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1- piperidinyl)ethoxy]phenyl]-, hydrochloride. Raloxifene hydrochloride (HCl) has the empirical formula C28H27NO4S•HCl, which corresponds to a molecular weight of 510.05. Raloxifene HCl is an offwhite to pale-yellow solid that is very slightly soluble in water.
EVISTA is supplied in a tablet dosage form for oral administration. Each EVISTA tablet contains 60 mg of raloxifene HCl, which is the molar equivalent of 55.71 mg of free base. Inactive ingredients include anhydrous lactose, carnauba wax, crospovidone, FD&C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate 80, povidone, propylene glycol, and titanium dioxide.

Raloxifene Hydrochloride Effects:

-Treatment and prevention of osteoporosis in postmenopausal women.
-Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and/or at high risk of invasive breast cancer.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s